Follow @UKGovscan on X for updates and inquiries

UKGovscanBETA

BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.

Loading contract…

PHE - Corporate - Sickle Cell and Thalassaemia Screening Programme — Public Health England | UKGovscan

ENDEDProcurement notice · Public Health EnglandRef ocds-b5fd17-dad92333-418a-494b-ad54-24f6e10cd19f

PHE - Corporate - Sickle Cell and Thalassaemia Screening Programme

Save Track Track buyer

Published

17 Aug 2021

Awarded

17 Aug 2021

Started

17 Aug 2021

Ended

30 Dec 2022

Total Awarded

£80,464

Contract Term

16 months

17 Aug 2021 – 30 Dec 2022

Supplier

Costello Medical

Company 06746770

Procurement

Other -

Source

Contracts Finder

View original notice

Description

Minimum acceptable performance criteria for designing test accuracy studies of cfDNA within the UK Sickle Cell and Thalassaemia Screening Programme: a decision analytic model.

Buyer

Organisation: Public Health England
Buyer ID: GB-CFS-174493
Local Authority Code: –
Address: Wellington House, 133-155 Waterloo Road, London, SE1 8UG, GB

Supplier

Supplier	Identifier	Award Value	Cross-References
Costello Medical	06746770	£80,464	-

Key Dates

Published: 17 August 2021
Tender Open: -
Tender Deadline: 20 July 2021
Award Date: 17 August 2021
Contract Start: 17 August 2021
Contract End: 30 December 2022

Procurement Details

Method: –
Method Details: Other -
Main category: Services
Category: –
Buyer Reference: CF-0311400D0O000000rwimUAA1
CPV Codes: 75122000 – Administrative healthcare services

Tender Documents

Awarded contract notice on Contracts Finder → — Award notice

Loading contract…